株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

主要7カ国のサイトメガロウイルス (CMV) 感染症:疫学的予測

Cytomegalovirus (CMV) Infection- Epidemiology Forecast to 2028

発行 DelveInsight Business Research LLP 商品コード 402149
出版日 ページ情報 英文 50 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.98円で換算しております。
Back to Top
主要7カ国のサイトメガロウイルス (CMV) 感染症:疫学的予測 Cytomegalovirus (CMV) Infection- Epidemiology Forecast to 2028
出版日: 2019年01月01日 ページ情報: 英文 50 Pages
概要

当レポートでは、主要7カ国におけるサイトメガロウイルス (CMV) の感染動向を調査し、疾患の背景、臨床症状、リスク要因、病態生理、主要7カ国 (米国・ドイツ・フランス・イタリア・スペイン・英国・日本) における総有病者数、ハイリスク新生児、移植患者およびHIV患者における感染者数、抗体保有者数の推移と予測などをまとめています。

第1章 重要考察

第2章 疾患概要:サイトメガロウイルス (CMV) 感染症

  • イントロダクション
  • CMV感染症の臨床症状
  • 病因
  • リスク要因
  • 遺伝パターン
  • 兆候・症状
  • 病態生理
    • 遺伝子型解析
  • 診断
    • 鑑別診断
    • 診断基準
    • 勧告

第3章 疫学・患者人口

  • 主要調査結果
  • 人口・予測パラメーター

第4章 主要7カ国の総有病者数

第5章 CMV感染症の疫学:国別

  • 米国
    • 有病者人口
    • 有病者人口:区分別
    • 有病者人口:デノボ変異
  • ドイツ
    • 有病者人口
    • 有病者人口:区分別
    • 有病者人口:デノボ変異
  • フランス
    • 有病者人口
    • 有病者人口:区分別
    • 有病者人口:デノボ変異
  • イタリア
    • 有病者人口
    • 有病者人口:区分別
    • 有病者人口:デノボ変異
  • スぺイン
    • 有病者人口
    • 有病者人口:区分別
    • 有病者人口:デノボ変異
  • 英国
    • 有病者人口
    • 有病者人口:区分別
    • 有病者人口:デノボ変異
  • 日本
    • 有病者人口
    • 有病者人口:区分別
    • 有病者人口:デノボ変異

第6章 付録

第7章 DelveInsightの能力

第8章 免責事項

第9章 DelveInsightについて

図表

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)
目次
Product Code: DIEI0007

DelveInsight's "Cytomegalovirus (CMV) Infection - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Cytomegalovirus (CMV) Infection epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Cytomegalovirus (CMV) Infection Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Cytomegalovirus (CMV) Infection in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Cytomegalovirus (CMV) Infection outlook. It also includes the explanation of changing trends of epidemiology outlining the Cytomegalovirus (CMV) Infection scenario.

Cytomegalovirus (CMV) Infection Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Cytomegalovirus (CMV) Infection thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Cytomegalovirus (CMV) Infection explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Cytomegalovirus (CMV) Infection Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Cytomegalovirus (CMV) Infection

Key assessments

  • Patient Segmentation in Cytomegalovirus (CMV) Infection
  • Cytomegalovirus (CMV) Infection Risk & Burden
  • Factors driving growth in a specific Cytomegalovirus (CMV) Infection patient population

Table of Contents

1. Report Introduction

2. Cytomegalovirus (CMV) Infection Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Cytomegalovirus (CMV) Infection in 2016
  • 2.2. Patient Share Distribution of Cytomegalovirus (CMV) Infection in 2028

3. Disease Background and Overview: Cytomegalovirus (CMV) Infection

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Cytomegalovirus (CMV) Infection in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Cytomegalovirus (CMV) Infection in 7MM - By Countries

5. Epidemiology of Cytomegalovirus (CMV) Infection by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.1.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection *
    • 5.1.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.1.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.4.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.4.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.4.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.5.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.5.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.5.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.6.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.6.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.6.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.7.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.7.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.7.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.8.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.8.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.8.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.9.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.9.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.9.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection

6. Unmet Needs of the Cytomegalovirus (CMV) Infection

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

Back to Top